Please login to the form below
OPMD
This page shows the latest OPMD news and features for those working in and with pharma, biotech and healthcare.
Axovant drops last ‘legacy’ drug to focus on gene therapies
That was followed swiftly by a $10m upfront deal with Benitec Biopharma for rights to a preclinical stage gene therapy for rare disease oculopharyngeal muscular dystrophy (OPMD), due to start trials
Latest news
-
Axovant licenses another gene therapy as new strategy beds in
According to Axovant, patients with OPMD develop swallowing difficulties that can have potentially life-threating consequences, including malnutrition and aspiration pneumonia. ... I am excited about the potential of this platform for patients suffering
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Events Executive
-
DOE
- Account Manager – Healthcare advertising
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director – UK Office
-
Excellent salary and benefits
Subscribe to our email news alerts
- Envision Pharma Group relocates to support expansion
- A roadmap to the successful treatment of Alzheimer’s disease
- Novartis eyes potential new indication for Cosentyx
- Acceleron scraps rare muscular dystrophy drug
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- New data backs GeNeuro’s MS drug after Servier exit
PMHub
Kendle Healthcare
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...
Latest intelligence
- A roadmap to the successful treatment of Alzheimer’s disease
- Building on past research to learn more about the disease and how to treat it...
- Article: Like, Like, Like: Harnessing the power of social media insights
- ...
- Its Know Your Numbers week
- Do you know yours?...
Quick links
Infographics
